Cardiol Therapeutics Inc. Description Of Option Life Share Options Granted
Cardiol Therapeutics Inc. (CRDL) reported Description Of Option Life Share Options Granted of 4.2 Y for the 12-month period ending 2025-12-31, per its 40-F filed 2026-03-31.
Financial Statements › Notes
ifrs-full:DescriptionOfOptionLifeShareOptionsGranted · last filed 2026-03-31
USD
| Period end | Description Of Option Life Share Options Granted 12 month |
|---|---|
| 2022-12-31 | $5.00 20-F · filed 2023-03-29 |
| 2021-12-31 | $3.71 20-F · filed 2023-03-29 |
| 2020-12-31 | $3.01 40-F/A · filed 2022-04-20 |
Y
| Period end | Description Of Option Life Share Options Granted 12 month |
|---|---|
| 2025-12-31 | 4.20 Y 40-F · filed 2026-03-31 |
| 2024-12-31 | 3.25 Y 40-F · filed 2026-03-31 |
| 2023-12-31 | 4.09 Y 40-F · filed 2025-03-31 |
| 2022-12-31 | 5.00 Y 20-F · filed 2024-04-01 |
| 2021-12-31 | 3.71 Y 20-F · filed 2024-04-01 |
| 2020-12-31 | 3.01 Y 20-F · filed 2023-03-29 |